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Identity 




The gene spans approximately 60 kb; 6 exons. 
Transcription 
2.6 kb mRNA; two transcription initiation sites. 
Protein 
Description 
228 amino acids; 26 kDa; contains a basic region/helix-
loop-helix/leucine zipper (B-HLH-LZ) motif that is 
similar to that found in Myc family. 
Expression 





Mxil, discovered in 1993, is, with Mad, one of the 
proteins that can regulate Max, a human protein 
containing a basic helix-loop-helix leucine zipper 
(bHLH-zip) that allows the formation of cMyc-Max 
heterodimers and that activates transcription; Mad an
Mxil may be involved in tumour suppression since thy 
can compete with Myc proteins for the interaction with 
Max; Mxil normally functions to suppress cell growth: 
experimental induction of the gene resulted in the 
accumulation of cells in G2-M phase. 
Homology 




Mutations have been described in some sporadic 
prostate cancers but no germline mutations were found 
in a study of 38 families with possible predispositi n to 
this disease; a correlation between a polymorphic 
repeat in the 3' untranslated region in Mxil mRNA and 
regulation of its transcription and degradation hasbeen 
suggested. 
Implicated in 
Implicated in some sporadic cases of prostate 
cancer and glioblastoma as a tumour 
suppressor gene 
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